Guggenheim Capital LLC Ampio Pharmaceuticals, Inc. Transaction History

Guggenheim Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$1.66 - $3.82 $35,777 - $82,332	-21,553 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$2.16 - $3.48 $3,954 - $6,371	1,831 Added 9.28%	21,553 $73,000
Q4 2017 Feb 14, 2018	SELL	$0.68 - $4.19 $2,258 - $13,914	-3,321 Reduced 14.41%	19,722 $80,000
Q3 2017 Nov 14, 2017	BUY	$0.38 - $0.66 $8,756 - $15,208	23,043	23,043 $14,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Guggenheim Capital LLC with notifications on news.